Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hib Disease”

191 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 191 results

Large-scale testing (Phase 3)Study completedNCT01019772
What this trial is testing

Immunogenicity and Safety Study of LBVH0101 in Healthy Infants at Two, Four and Six Months of Age

Who this might be right for
Infectious Disease by Haemophilus Influenzae Type b
LG Life Sciences 217
Large-scale testing (Phase 3)Study completedNCT00313911
What this trial is testing

Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Sanofi Pasteur, a Sanofi Company 2,133
Large-scale testing (Phase 3)Study completedNCT02447432
What this trial is testing

Compare the Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorix™ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy Infants

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 320
Large-scale testing (Phase 3)Study completedNCT00621504
What this trial is testing

Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia

Who this might be right for
Bacterial Pneumonia
Forest Laboratories 606
Testing effectiveness (Phase 2)Study completedNCT00289796
What this trial is testing

Assess Feasibility of an Acellular Pertussis Vaccine (Pa) Given Soon After Birth, Followed by 3-dose Primary Vaccination With the DTPa-HBV-IPV/Hib Vaccine

Who this might be right for
Hepatitis B
GlaxoSmithKline 121
Not applicableStudy completedNCT04747184
What this trial is testing

Variations in the Composition of Respiratory Microbiota

Who this might be right for
Asthma
Applied Science Private University 54
Not applicableStudy completedNCT02294487
What this trial is testing

Study of the Immune Response After Vaccination in Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaMyeloma, MultipleMyeloma-Multiple
Wake Forest University Health Sciences 19
Large-scale testing (Phase 3)Study completedNCT00169442
What this trial is testing

Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants

Who this might be right for
Whole Cell PertussisDiphtheriaHepatitis B+2 more
GlaxoSmithKline 745
Post-approval studies (Phase 4)Study completedNCT02853929
What this trial is testing

Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery

Who this might be right for
DiphtheriaHepatitis BAcellular Pertussis+4 more
GlaxoSmithKline 551
Large-scale testing (Phase 3)Study completedNCT01062477
What this trial is testing

DTaP//PRP-T Combined Vaccine (ACTACEL) Versus Local DTaP and Act-HIB Monovalent Vaccine in Healthy Infants

Who this might be right for
DiphtheriaTetanusPertussis+1 more
Sanofi 1,056
Large-scale testing (Phase 3)Study completedNCT00441012
What this trial is testing

Study of Modified Process Hib/Hep B Vaccine in Infants (V121-019)(COMPLETED)

Who this might be right for
Haemophilus Influenzae Type BHepatitis B
Merck Sharp & Dohme LLC 546
Testing effectiveness (Phase 2)Study completedNCT00135486
What this trial is testing

Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT Vaccine and Hib-MenC-TT Vaccine in Infants

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 500
Testing effectiveness (Phase 2)Study completedNCT00158808
What this trial is testing

Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 Mths

Who this might be right for
Hib DiseaseHepatitis BPertussis+2 more
GlaxoSmithKline 175
Large-scale testing (Phase 3)Study completedNCT01309646
What this trial is testing

Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib Vaccine

Who this might be right for
PoliomyelitisTetanusAcellular Pertussis+2 more
GlaxoSmithKline 454
Large-scale testing (Phase 3)Study completedNCT00317161
What this trial is testing

Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose.

Who this might be right for
DiphtheriaHepatitis BHaemophilus Influenzae Type b+2 more
GlaxoSmithKline 1,000
Large-scale testing (Phase 3)Study completedNCT01353703
What this trial is testing

Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine

Who this might be right for
PoliomyelitisTetanusAcellular Pertussis+4 more
GlaxoSmithKline 224
Post-approval studies (Phase 4)Study completedNCT01491087
What this trial is testing

Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China

Who this might be right for
DiphtheriaTetanusPertussis+1 more
Sanofi Pasteur, a Sanofi Company 900
Large-scale testing (Phase 3)Study completedNCT00197275
What this trial is testing

Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in Infants

Who this might be right for
TetanusHepatitis BHaemophilus Influenzae Type b+2 more
GlaxoSmithKline 800
Large-scale testing (Phase 3)Study completedNCT00880477
What this trial is testing

Immunogenicity and Safety of Primary and Booster Vaccination With DTPa-HBV-IPV/Hib Vaccine

Who this might be right for
Hepatitis B
GlaxoSmithKline 140
Testing effectiveness (Phase 2)Study completedNCT00970307
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age

Who this might be right for
TetanusDiphtheriaHaemophilus Influenzae Type b+4 more
GlaxoSmithKline 421
Next Page